Skip to Content
Morningstar

Charles River Laboratories International Inc CRL

Morningstar Rating
Unlock
Stock XNYS Rating as of
$227.81 −11.62 (4.85%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Price vs Fair Value

View History
CRL is trading at a 11% discount.
Price
$232.56
Fair Value
$836.00
Uncertainty
Medium
1-Star Price
$532.00
5-Star Price
$418.00
Economic Moat
Xzzktmp
Capital Allocation
Dkxpqzf

Bulls Say, Bears Say

Bulls

Charles River’s reputation for quality and scientific expertise supports its leading position in the research model and preclinical trial markets.

Bears

Charles River does not have a long-term advantage in drug discovery, as we believe that will remain the core competency of biotechnology and pharmaceutical companies.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CRL is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$239.43
Day Range
$225.97–237.31
52-Week Range
$161.65–275.00
Bid/Ask
$208.09 / $261.89
Market Cap
$11.73 Bil
Volume/Avg
762,872 / 540,639

Key Statistics

Price/Earnings (Normalized)
21.39
Price/Sales
2.84
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
0.21%

Company Profile

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Core
Total Number of Employees
21,400
Website
https://www.criver.com

Competitors

Valuation

View More
Metric
CRL
FTRE
ICLR
Price/Earnings (Normalized)
 21.3965.3724.33
Price/Book Value
 3.251.862.63
Price/Sales
 2.841.043.02
Price/Cash Flow
 14.9126.5518.63
Price/Earnings
CRL
FTRE
ICLR

Financial Strength

Metric
CRL
FTRE
ICLR
Quick Ratio
 1.001.521.16
Current Ratio
 1.521.621.21
Interest Coverage
 5.211.023.37
Quick Ratio
CRL
FTRE
ICLR

Profitability

Metric
CRL
FTRE
ICLR
Return on Assets (Normalized)
 7.06%1.15%4.85%
Return on Equity (Normalized)
 16.90%2.40%9.19%
Return on Invested Capital (Normalized)
 10.34%3.06%8.41%
Return on Assets
CRL
FTRE
ICLR
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Diagnostics & Research Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncHwjsjbhfzhVggw$209.3 Bil
DHR
Danaher CorpSghrbfydqMgkwbh$182.1 Bil
IQV
IQVIA Holdings IncStwpmkzwWmbky$43.4 Bil
IDXX
IDEXX Laboratories IncNrsydgktgcJhsbpt$41.0 Bil
A
Agilent Technologies IncCvqpqqtfzLyrg$40.3 Bil
MTD
Mettler-Toledo International IncKxxtsqzvhxSqnlc$26.4 Bil
ICLR
Icon PLCYpdclnxKkqqjl$24.8 Bil
ILMN
Illumina IncZhjfzqnCdvhhq$19.3 Bil
WAT
Waters CorpGwzsygwfmPmj$18.3 Bil
LH
Laboratory Corp of America HoldingsMfgqbnpzmVmbzmh$17.5 Bil

Sponsor Center